Assessment of Adults Epidemiological Characteristics of Status Epilepticus in the French West Indies and in French Guiana
Launched by UNIVERSITY HOSPITAL CENTER OF MARTINIQUE · Feb 9, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into a serious condition called Status Epilepticus (SE), which is a prolonged seizure that can lead to significant health problems. Researchers want to better understand how common SE is in the French West Indies and French Guiana, as well as its causes and outcomes. This information is important because while SE can be very serious, the health risks and chances of recovery in these regions are not well-known.
To participate in this study, you need to be an adult (18 years or older) who has been treated for SE in the French West Indies or French Guiana. Participants will be asked to allow researchers to use their medical information to help improve understanding of SE. If you or a family member are eligible and decide to join, you can expect to contribute valuable information that may help improve treatment and outcomes for others with this condition in the future. Your involvement could play a key role in understanding how to better manage SE in these regions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients (≥ 18 years old) treated for SE by SAMU/SMUR and by emergencies or intensive care in the French West Indies and French Guiana.
- * Covered for suspected or SE diagnosis defined by one of the following:
- • a prolonged generalized tonic-clonic crisis lasting more than 5 minutes and accompanied by impaired consciousness or at least 2 generalized tonic-clonic crisis without return to normal consciousness between crisis.
- • a focal convulsive crisis (motor or not) with disturbances of consciousness which lasts beyond 10 minutes or crisis which are repeated (≥ 2) at short intervals without recovery of interictal consciousness.
- • a focal convulsive crisis (motor or not) without alteration of consciousness that lasts beyond 10 to 15 minutes.
- • an absence-type crisis that lasts longer than 10 to 15 minutes.
- • a myoclonic, clonic and tonic crisis that lasts longer than 10 to 15 minutes.
- • a coma with an epileptic cause diagnosed on an EEG.
- • Patient if he is able to, or representative of the patient in case of incapacity, having given his agreement for the use of his medical data for this research.
- Exclusion Criteria:
- • Age \< 18 years old
- • Absence of consent from the patient, or representative to the use of the data for the research.
- • Patient whose main residence is not in the department where the study is taking place (vacationer for example).
About University Hospital Center Of Martinique
The University Hospital Center of Martinique (CHUM) is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. As a prominent academic hospital, CHUM integrates cutting-edge research with clinical practice, fostering collaborations among healthcare professionals, researchers, and academic partners. The center is committed to enhancing health outcomes in the Caribbean region by focusing on a diverse range of medical disciplines, ensuring the highest standards of ethical conduct and patient safety in all trials. Through its comprehensive approach, CHUM aims to contribute significantly to medical knowledge and the development of effective treatment options for various health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Fort De France, Martinique, France
Cayenne, French Guiana, France
Basse Terre, Guadeloupe, France
Pointe à Pitre, Guadeloupe, France
Patients applied
Trial Officials
Florian Negrello, MD
Principal Investigator
University Hospital Center of Martinique
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials